GREY:TBPMQ - Post by User
Post by
SamV21on Oct 24, 2021 4:19pm
141 Views
Post# 34042365
Second choice now I guess .Not the first ?, not the only ?
Second choice now I guess .Not the first ?, not the only ? Right out of Tetras play book from September 2020
In the current context of cannabis legalization and significant shortages of nabilone, a drug used for chemotherapy-induced nausea and vomiting, our goal is to relaunch a high value therapeutic option with robust data. Under the terms of the agreement, TBP has agreed to acquire Dronabinol Soft Gel capsules commercial rights for two undisclosed milestones, 50% at the approval of the transaction and the other 50% once the DIN is granted by Health Canada.I guess that is why they can not give net numbers on income from it , undisclosed expences.
Dronabinol Soft Gel capsules are indicated in AIDS-related anorexia associated with weight loss and severe nausea and vomiting associated with cancer chemotherapy. Dronabinol DIN launch is expected in the first-half of 2021............We are now the the 4th Quarter of 2021 .
How are those milestones coming along ?
and you wonder why the price keeps going down, we have not seen the end of the drop in share price yet not by a long shot.
More fluff discussions , mean nothing , what is he going to say, you believe the garbage I'm sticking with results and the facts.Qixleef is light years away from being anything and Syqe has a product who Teva and Tilray are working on that is Health Canada approved already.